SRx Health enters waiver for new Series B preferred stock offering

SRx Health Solutions, Inc.

Existing investors waive participation rights and consent to Series B Preferred Stock ranking pari passu with Series A.
New offering of Series B Preferred Stock and related warrants planned under a new securities purchase agreement.
Waiver relates to prior July 2025 note financing and October 2025 Series A financing agreements.
Company must file Form 8-K disclosing material non-public information by next business day.
Effective date of waiver is upon receipt of identical agreements from other holders.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.4

SRx Health Solutions, Inc. entered into Waiver with certain Existing Investors.

Action: entry
Counterparty: certain Existing Investors

Exact text from the filing

certain Existing Investors have each entered into a limited waiver and consent agreement with the Company (each, a “Waiver”)

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.4

SRx Health Solutions, Inc. entered into New Securities Purchase Agreement with certain accredited investors.

Action: entry
Agreement: equity purchase
Counterparty: certain accredited investors

Exact text from the filing

The Company desires to enter into a securities purchase agreement (the “New Securities Purchase Agreement”) with certain accredited investors (the “New Buyers”)

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-008656

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.